MAC Vanguard Presenters

Formerly AAI Minority Affairs Committee (MAC) Guest Lecture

Since 2003, the AAI Annual Meeting has featured a minority scientist guest lecture sponsored by the AAI Minority Affairs Committee. The lecture series features AAI members who are under-represented minority scientists as defined by eligibility to participate in the Minority Access to Research Resources (MARC) Program of the National Institute of General Medical Sciences (NIGMS), NIH. Following are past AAI Vanguard (MAC Guest) Lecturers.

Note: lecturers' institutional affiliations reflect their affiliations at the time of their AAI presentation.

2021

De’Broski R. Herbert, Ph.D.
Univ. of Pennsylvania Sch. of Vet. Med.
IL-33 regulates the balance between inflammation and immunosuppression

2019

Margaret S. Bynoe, Ph.D.
Cornell University College of Veterinary Medicine
Adenosine receptor axis in blood brain barrier (BBB) permeability regulation

2018

Elina Zúñiga, Ph.D.
University of California, San Diego
The art of coexistence: immune adaptations during chronic viral infections

2017

Tyler J. Curiel, M.D., M.P.H.
The University of Texas Health Science Center at San Antonio
Advancing towards optimized cancer immunotherapy

2016

Prosper N. Boyaka, Ph.D.
Ohio State University
Diversity: Lessons from regulation of mucosal immunity by toxins and microbiota

2015

Gabriel Núñez, M.D.
University of Michigan
Linking pathogen virulence, immunity, and the microbiota

2014

Arturo Casadevall, Ph.D.
Albert Einstein College of Medicine, Yeshiva University
A new synthesis for antibody-mediated immunity

2013

Esteban Celis, Ph.D.
Moffitt Cancer Center, University of South Florida
The long road to effective peptide vaccines for cancer: learning from infectious diseases and autoimmunity

2012

Charles E. Egwuagu, M.P.H., Ph.D.
National Eye Institute, National Institutes of Health
Regulation of autoreactive lymphocytes that mediate CNS autoimmune diseases

2011

Olivia M. Martinez, Ph.D.
Stanford School of Medicine
Effects of viral proteins on lymphocyte function in Epstein Barr Virus B cell lymphomas

2010

Albert Zlotnik, Ph.D.
University of California, Irvine
An evolutionary view of chemokines

2009

Emil R. Unanue, M.D.
Washington University School of Medicine
The mysteries of peptide selection by the class II MHC molecules

2008

Juan J. Lafaille, Ph.D.
New York University School of Medicine
Antigen-induced Foxp3+ regulatory T cells

2007

Avery August, Ph.D.
Pennsylvania State University
Tec tyrosine kinase modulation of airway responses

2006

Diana M. Lopez, Ph.D.
University of Miami
A unique mucin immunoenhancing peptide with anti-tumor properties

2005

Juan Carlos Zúñiga-Pflücker, Ph.D.
Sunnybrook and Women’s Research Institute, University of Toronto
Becoming a T cell: lineage options and decisions by stem cells

2004

Randy R. Brutkiewicz, Ph.D.
Indiana University School of Medicine
CD1d-mediated antigen presentation to NKT Cells

2003

Richard A. Goldsby, Ph.D.
Amherst College
Human antibody from human artificial chromosome transgenic cloned cattle

© The American Association of Immunologists, Inc.
1451 Rockville Pike, Suite 650, Rockville, Maryland 20852
Phone: (301) 634-7178 | Fax: (301) 634-7887